![Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant | mBio Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant | mBio](https://journals.asm.org/cms/10.1128/mbio.00416-23/asset/d0f16a8f-dd7b-43cf-ad70-899ebf599d75/assets/images/medium/mbio.00416-23-f003.gif)
Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant | mBio
Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 delta and bey
Rosanna Verde - Full Professor of Statistics - Università della Campania "Luigi Vanvitelli" | LinkedIn
![Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection | Science Immunology Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.abd0205/asset/ad75cf75-9bd0-4e82-bb37-725c4f23f2d0/assets/images/large/sciimmunol.abd0205-f1.jpg)
Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection | Science Immunology
![Frontiers | SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines Frontiers | SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines](https://www.frontiersin.org/files/MyHome%20Article%20Library/1130539/1130539_Thumb_400.jpg)